Medizinisches Zentrum für Hämatologie und Onkologie

München 80639

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Triple Negative Breast Neoplasms

Studies at this site

• A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer — Completed
• A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE) — Completed